Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
29.58
-0.55 (-1.83%)
Aug 6, 2026, 3:25 PM EDT - Market open

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
US Revenue
3.31B3.31B3.12B
Other Established Markets Revenue
1.92B1.86B1.71B
Total Established Markets Revenue
5.23B5.16B4.83B
Emerging Markets Revenue
1.08B1.00B980.00M
Revenue (Other)
-1.00M--
Revenue (Total)
6.30B6.16B5.81B

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Knee Implants Revenue
1.00B1.01B977.00M
Hip Implants Revenue
655.00M641.00M619.00M
Other Reconstruction Revenue
139.00M136.00M101.00M
Trauma & Extremities Revenue
661.00M649.00M608.00M
Total Orthopaedics Revenue
2.46B2.44B2.31B
Sports Medicine Joint Repair Revenue
1.13B1.07B982.00M
Arthroscopic Enabling Technologies Revenue
681.00M647.00M632.00M
ENT (Ear, Nose and Throat) Revenue
216.00M220.00M210.00M
Total Sports Medicine & ENT Revenue
2.03B1.93B1.82B
Advanced Wound Care Revenue
798.00M766.00M735.00M
Advanced Wound Bioactives Revenue
600.00M621.00M581.00M
Advanced Wound Devices Revenue
418.00M406.00M365.00M
Total Advanced Wound Management Revenue
1.82B1.79B1.68B
Revenue (Other)
-1.00M--
Revenue (Total)
6.30B6.16B5.81B

Adjusted EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Orthopaedics Segment Profit
-363.00M265.00M
Sports Medicine & ENT Segment Profit
-461.00M437.00M
Advanced Wound Management Segment Profit
-447.00M399.00M
Operating Income (Total)
813.00M794.00M657.00M